[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Alnouri, 2016 - Google Patents

The human 7-transmembrane orphan receptor family MRGPRX: native expression and identification, development and pharmacological characterization of agonists …

Alnouri, 2016

View PDF
Document ID
8868825808204142618
Author
Alnouri M
Publication year

External Links

Snippet

The human MRGPRX receptors belong to the orphan 7-transmembrane receptors (7TMRs) within the Rhodopsin family of 7TMRs. The MRGPRX receptor subfamily is exclusively expressed in primates, which represents a hurdle for elucidating the (patho) physiological …
Continue reading at bonndoc.ulb.uni-bonn.de (PDF) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds

Similar Documents

Publication Publication Date Title
Meyrath et al. The atypical chemokine receptor ACKR3/CXCR7 is a broad-spectrum scavenger for opioid peptides
Brady et al. G protein-coupled receptor interacting proteins: emerging roles in localization and signal transduction
Wang et al. Teneurin proteins possess a carboxy terminal sequence with neuromodulatory activity
Stroth et al. S100B interacts with the serotonin 5-HT7 receptor to regulate a depressive-like behavior
Wang et al. Structure-based optimization of multifunctional agonists for opioid and neuropeptide FF receptors with potent nontolerance forming analgesic activities
Dishon et al. Development of a novel backbone cyclic peptide inhibitor of the innate immune TLR/IL1R signaling protein MyD88
Fabbretti et al. Regulation of P2X3 receptor structure and function
KR20220124196A (en) Cyclic peptide receptor lanthionine synthetase C-like protein (LANCL) and uses thereof
Verkest et al. C-Jun N-terminal kinase post-translational regulation of pain-related acid-sensing ion channels 1b and 3
SG187877A1 (en) Novel peptides which have analgesic effects and which inhibit asic channels
Wei et al. The nuclear cytokine IL-37a controls lethal cytokine storms primarily via IL-1R8-independent transcriptional upregulation of PPARγ
Alnouri The human 7-transmembrane orphan receptor family MRGPRX: native expression and identification, development and pharmacological characterization of agonists and antagonists
Xu et al. NaV1. 7 Channel Blocker [Ala5, Phe6, Leu26, Arg28] GpTx-1 Attenuates CFA-induced Inflammatory Hypersensitivity in Rats via Endogenous Enkephalin Mechanism
Mak et al. In vivo actions of SCTR/AT1aR heteromer in controlling Vp expression and release via cFos/cAMP/CREB pathway in magnocellular neurons of PVN
CA2565731C (en) Analog compounds of analgesic peptides derived from the venom of crotalus durissus terrificus snakes, their uses, compositions, methods of preparation and purification
KR100971270B1 (en) EPF Receptor Assays, Compounds and Therapeutic Compositions
CN112359034B (en) Polypeptide inhibitor and application thereof
KR20090109932A (en) Glycogen synthase kinase beta inhibitor
US10738095B2 (en) Engineered CCL20 locked dimer polypeptide
US11571462B2 (en) Engineered CCL20 locked dimer polypeptide
JP2012514992A (en) Identification of a toxin that is a novel antagonist of T-type calcium channel for the purpose of analgesia
Belisario et al. Purification and characterization of the ouabain-sensitive H+/K+-ATPase from guinea-pig distal colon
Doyle Characterization of calcium regulated adenylyl cyclases
Cechová The effects of opioid ligands on their receptors in model cells (eg lymphocytes, neural cells, cell lines)
Hassani Nia Autism-associated mutations interfere with the function of the Shank3 N-terminus in postsynaptic signaling pathways